Skip to main content

Table 1 Non-compartmental analysis of artemether and dihydroartemisinin pharmacokinetics in twelve healthy Pakistani subjects

From: Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine

 

Artemether

Dihydroartemisinin

 

Mean ± SD

Median (range)

Mean ± SD

Median (range)

Body-weight (kg)

69.9 ± 10

69.0 (51.0-83.0)

69.9 ± 10

69.0 (51.0-83.0)

Dose (mg/kg)

1.17 ± 0.18

1.16 (0.960-1.57)

1.11 ± 0.17

1.10 (0.92-1.49)

TLAG (hr)

0.130 ± 0.23

0 (0-0.75)

0.250 ± 0.24

0.250 (0-0.75)

CMAX (ng/mL)

184 ± 100

173 (54.2-363)

126 ± 46

122 (53.7-195)

CMAX/dose (kg × ng/mL × mg)

160 ± 86

148 (34.6-299)

113 ± 38

107 (57.1-169)

TMAX (hr)

1.56 ± 0.68

1.50 (0.500-3.00)

1.69 ± 0.59

1.50 (0.750-3.00)

CL/F (L/hr)

257 ± 140

222 (119-609)

269 ± 57

246 (209-383)

CL/F (L/hr × kg)

3.89 ± 2.8

3.11 (1.57-11.9)

3.87 ± 0.74

3.70 (3.05-5.27)

VZ/F (L)

666 ± 220

651 (342-1150)

702 ± 220

643 (456-1190)

VZ/F (L/kg)

9.85 ± 4.5

8.68 (5.02-22.5)

10.1 ± 2.6

9.63 (6.61-14.6)

T1/2 (hr)

2.00 ± 0.71

1.88 (1.24-4.00)

1.80 ± 0.31

1.78 (1.34-2.20)

AUC0-LAST (hr × ng/mL)

379 ± 170

362 (128-664)

287 ± 60

303 (196-361)

AUC0-∞ (hr × ng/mL)

385 ± 170

370 (131-671)

294 ± 58

311 (199-365)

AUC0-∞/dose (kg × hr × ng/mL × mg)

339 ± 160

322 (83.8-638)

267 ± 48

270 (190-327)

Extrapolated AUC0-∞ (%)

1.75 ± 0.99

1.43 (0.90-4.26)

2.59 ± 2.2

1.71 (0.73-8.76)

  1. TLAG = absorption lag time, CMAX = maximum observed plasma drug concentration, TMAX = observed time to reach CMAX, CL/F = oral clearance, VZ/F = apparent oral volume of distribution based on the terminal phase, T1/2 = terminal elimination half-life, AUC0-LAST = area under the plasma concentration time curve after the first dose to the last sampling time, AUC0-∞ = area under the plasma concentration time curve after the first dose to infinity, and Extrapolated AUC0-∞ = percentage of AUC0-∞ due to extrapolation from last measured concentration to infinity.